Medicare Plans Are Discouraging Generics Use

AAM Urges Policy Update Following Avalere Report

An AAM-sponsored study by researcher Avalere Health has concluded that Medicare Part D policy changes have led to generics being placed on non-generic tiers 53% of the time in 2020, with generics placed on the ‘preferred generic’ Tier 1 just 10% of the time.

Dollars_Pills
Avalere’s study suggests that US patients are being forced to pay more for generics • Source: Shutterstock

Medicare Part D policies must be revised to prevent patients from being discouraged from using generics, the US Association for Accessible Medicines has urged following the findings of an Avalere Health study.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Generics Bulletin